Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tyrosur Gel for Wound Healing
NCT01227759Phase 2
Key facts
- Status
- Completed
- Start
- Sep 2010
- Primary completion
- Oct 2010
- Sponsor
- Engelhard Arzneimittel
- Drugs
- Tyrosur
- Conditions
- wound
01
Overview
Phase 2, randomised, single-blind trial of Tyrosur in wound (3 arms), sponsored by Engelhard Arzneimittel. Primary endpoint: Clinical assessment of the wound healing efficacy of verum compared to untreated using a score for wound healing rates at 12 days. Started Sep 2010; status: completed.
02
Design
3 arms- Study design
- RandomizedSingle-blind
Verum
Tyrosur Gel applied to abrasive wounds.
Untreated
No treatment applied to abrasive wounds.
Vehicle
Placebo gel applied to abrasive wounds.
03
Who it enrols
Healthy volunteers aged 18 or older with healthy skin in the test area, excluding those with conditions like diabetes, psoriasis, or history of wound-healing complications.
04
Endpoints
Primary
Clinical assessment of the wound healing efficacy of verum compared to untreated using a score for wound healing rates
Secondary
Clinical assessment of the wound healing efficacy of the vehicle compared to untreated using a score for wound healing rates
Photo documentation of the wound healing efficacy
Beyond the preview
Go deeper on NCT01227759.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01227759.